Surgical Infection Rate Higher with RA DrugsArthritis Today… hydroxychloroquine (Plaquenil), azathioprine (Azasan, Imuran), cyclosporine (Neoral, Gengraf) and gold (Aurofin); TNF inhibitors, including etanercept (Enbrel), adalimumab (Humira) and infl…
|
Cancer Immunotherapy: A breakthrough made through animal research
Speaking of Research For, example back in 2009 Emma Stokes wrote an article for this blog on the discovery and development of Rituximab, a chimeric antibody therapy that has revolutionized the treatment of B-cell cancers such as Non-Hodgkin’s lymphoma. This work has not … |
Clinical Oncology News |
Bruce Cheson, MD: How I Treat Follicular Lymphoma—Part II
Clinical Oncology News The role for maintenance rituximab or consolidation radioimmunotherapy remains controversial, as neither prolongs overall survival (OS). New therapies that target the cell surface, pathways downstream from the B-cell receptor, apoptotic pathways and … |
MedscapeIs Obinutuzumab the Drug to Watch in CLL?MedscapeMaintenance therapy in follicular lymphoma — for example, the PRIMA study and the SAKK study, in which different durations of continuous rituximab were applied — there were some updates of thes…
|
Shopping for Biotech Growth Names: Reni Benjamin
Trefis However, the standard of care for CLL is FCR—fludarabine, cytarabine and rituximab (Rituxan). The fludarabine/cytarabine is the chemotherapy part and rituximab is the monoclonal antibody. Pharmacyclics has shown a significant benefit in CLL using just … |
MedscapeNovel Agents: Making the Benefit Last in CLLMedscapeBruce D. Cheson, MD: Hello. I am Bruce Cheson, Deputy Chief of Hematology-Oncology, and Head of Hematology at Georgetown University Hospital at the Lombardi Comprehensive Cancer Center in Wash…
It Took Two to Fight LymphomadailyRxDr. Neelapu and his team tested combining the monoclonal antibody Rituximab (Rituxan) and an experimental medication called pidilizumab on 29 patients with relapsed follicular lymphoma. These researchers found that t…
Tailoring CLL Treatment to a TTTMedscapeThose patients who develop symptoms and are physically fit, or both, are treated with fludarabine/cyclophosphamide/rituximab (FCR) as the standard of care for first-line therapy. It is important that physically f…
Idelalisib Raises Eyebrows in LymphomaMedscapeTwo studies were presented providing results of the combination of each of these drugs with the classic R-CHOP [rituximab, cyclophosphamide, hydroxydaunorubicin, Oncovin (vincristine), prednisone]. One is a…
CLL Combos: And the Winner Is…MedscapeDr. Cheson: For years we have been arguing about use of fludarabine-cyclophosphamide (FC), fludarabine-rituximab (FR), fludarabine-cyclophasphamide-rituximab (FCR), or bendamustine-rituximab (BR). There have been…